These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21158979)

  • 1. Dendritic cells and immunity against cancer.
    Palucka K; Ueno H; Fay J; Banchereau J
    J Intern Med; 2011 Jan; 269(1):64-73. PubMed ID: 21158979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell subsets as vectors and targets for improved cancer therapy.
    Palucka K; Ueno H; Roberts L; Fay J; Banchereau J
    Curr Top Microbiol Immunol; 2011; 344():173-92. PubMed ID: 20490776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells: are they clinically relevant?
    Palucka K; Ueno H; Roberts L; Fay J; Banchereau J
    Cancer J; 2010; 16(4):318-24. PubMed ID: 20693842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building on dendritic cell subsets to improve cancer vaccines.
    Palucka K; Ueno H; Zurawski G; Fay J; Banchereau J
    Curr Opin Immunol; 2010 Apr; 22(2):258-63. PubMed ID: 20226644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.
    López M; Aguilera R; Pérez C; Mendoza-Naranjo A; Pereda C; Ramirez M; Ferrada C; Aguillón JC; Salazar-Onfray F
    Immunobiology; 2006; 211(1-2):127-36. PubMed ID: 16446177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing dendritic cells to generate cancer vaccines.
    Palucka K; Ueno H; Fay J; Banchereau J
    Ann N Y Acad Sci; 2009 Sep; 1174():88-98. PubMed ID: 19769741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies.
    Galati D; Zanotta S
    Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in cancer vaccines.
    Palucka K; Ueno H; Banchereau J
    J Immunol; 2011 Feb; 186(3):1325-31. PubMed ID: 21248270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J; Palucka AK
    Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-based immunotherapy: a basic review and recent advances.
    Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
    Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
    Huang FP; Chen YX; To CK
    Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering better immunotherapies via RNA interference.
    Sioud M
    Hum Vaccin Immunother; 2014; 10(11):3165-74. PubMed ID: 25483669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.
    Saxena M; Bhardwaj N
    Curr Opin Immunol; 2017 Aug; 47():35-43. PubMed ID: 28732279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade.
    Appleton E; Hassan J; Chan Wah Hak C; Sivamanoharan N; Wilkins A; Samson A; Ono M; Harrington KJ; Melcher A; Wennerberg E
    Front Immunol; 2021; 12():754436. PubMed ID: 34733287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.